Non-segmental Vitiligo
Also known as: NonSegmental Vitiligo
Drug | Drug Name | Drug Description |
---|---|---|
DB08877 | Ruxolitinib | A kinase inhibitor used to treat various types of myelofibrosis, polycythemia vera in patients who have not responded to or cannot tolerate hydroxyurea, and to treat graft-versus-host disease in cases that are refractory to steroid treatment. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01076 | Atorvastatin | 1 / 2 | Completed | 1 |
DB00641 | Simvastatin | 1 / 2 | Completed | 1 |
DB18855 | Povorcitinib | 2 | Completed | 1 |
DB15091 | Upadacitinib | 2 | Completed | 1 |
DB00563 | Methotrexate | 3 | Completed | 1 |
DB18855 | Povorcitinib | 3 | Recruiting | 2 |
DB08877 | Ruxolitinib | 3 | Completed | 2 |
DB08877 | Ruxolitinib | 3 | Not Yet Recruiting | 1 |
DB00654 | Latanoprost | 4 | Active Not Recruiting | 1 |